Cargando…

Correction: HP1β Is a Biomarker for Breast Cancer Prognosis and PARP Inhibitor Therapy

Detalles Bibliográficos
Autores principales: Lee, Young-Ho, Liu, Xiyong, Qiu, Fuming, O’Connor, Timothy R., Yen, Yun, Ann, David K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395453/
https://www.ncbi.nlm.nih.gov/pubmed/25875848
http://dx.doi.org/10.1371/journal.pone.0124853
_version_ 1782366453683453952
author Lee, Young-Ho
Liu, Xiyong
Qiu, Fuming
O’Connor, Timothy R.
Yen, Yun
Ann, David K.
author_facet Lee, Young-Ho
Liu, Xiyong
Qiu, Fuming
O’Connor, Timothy R.
Yen, Yun
Ann, David K.
author_sort Lee, Young-Ho
collection PubMed
description
format Online
Article
Text
id pubmed-4395453
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43954532015-04-21 Correction: HP1β Is a Biomarker for Breast Cancer Prognosis and PARP Inhibitor Therapy Lee, Young-Ho Liu, Xiyong Qiu, Fuming O’Connor, Timothy R. Yen, Yun Ann, David K. PLoS One Correction Public Library of Science 2015-04-13 /pmc/articles/PMC4395453/ /pubmed/25875848 http://dx.doi.org/10.1371/journal.pone.0124853 Text en © 2015 Lee et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Correction
Lee, Young-Ho
Liu, Xiyong
Qiu, Fuming
O’Connor, Timothy R.
Yen, Yun
Ann, David K.
Correction: HP1β Is a Biomarker for Breast Cancer Prognosis and PARP Inhibitor Therapy
title Correction: HP1β Is a Biomarker for Breast Cancer Prognosis and PARP Inhibitor Therapy
title_full Correction: HP1β Is a Biomarker for Breast Cancer Prognosis and PARP Inhibitor Therapy
title_fullStr Correction: HP1β Is a Biomarker for Breast Cancer Prognosis and PARP Inhibitor Therapy
title_full_unstemmed Correction: HP1β Is a Biomarker for Breast Cancer Prognosis and PARP Inhibitor Therapy
title_short Correction: HP1β Is a Biomarker for Breast Cancer Prognosis and PARP Inhibitor Therapy
title_sort correction: hp1β is a biomarker for breast cancer prognosis and parp inhibitor therapy
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395453/
https://www.ncbi.nlm.nih.gov/pubmed/25875848
http://dx.doi.org/10.1371/journal.pone.0124853
work_keys_str_mv AT leeyoungho correctionhp1bisabiomarkerforbreastcancerprognosisandparpinhibitortherapy
AT liuxiyong correctionhp1bisabiomarkerforbreastcancerprognosisandparpinhibitortherapy
AT qiufuming correctionhp1bisabiomarkerforbreastcancerprognosisandparpinhibitortherapy
AT oconnortimothyr correctionhp1bisabiomarkerforbreastcancerprognosisandparpinhibitortherapy
AT yenyun correctionhp1bisabiomarkerforbreastcancerprognosisandparpinhibitortherapy
AT anndavidk correctionhp1bisabiomarkerforbreastcancerprognosisandparpinhibitortherapy